💰 Business
Live
Sanofi Raises FY26 Outlook Amid Strong Dupixent Sales
Sanofi’s Q2 net profit fell due to one-time charges, but core business earnings rose 29% driven by Dupixent sales. This operational strength validates its strategic shift, prompting the company to rai
Nasdaq News — 29 July 2026
Text:
34
0
0
Sanofi reported a dramatic drop in its second-quarter net profit to €343 million, down sharply from €3.9 billion a year ago, even as its core business
Read Full Story at Nasdaq News → Sources
💰 Business
CXMT becomes most valuable listed company in mainland China at 3.3 trillion yuan
💰 Business
UK complacent about war threat, warns defence boss
💰 Business
Anne Sweeney Resigns From Netflix Board After 11 Years
💰 Business
France mandates 30 days leave, slowing July economy
💰 Business
Verve Signs ‘Off Campus’ EP Leanna Billings
💰 Business
Singapore stock market to open higher after Straits Times Index gains.
